Login / Signup

Ehrlichiosis infection mimicking thrombotic microangiopathy syndrome early after kidney transplantation.

Waleed HassanManish TalwarVasanthi BalaramanMiklos Z Molnar
Published in: Transplant infectious disease : an official journal of the Transplantation Society (2020)
Fever of unknown origin and the clinical picture of thrombotic microangiopathy (TMA) are diagnostic challenges in the early period after kidney transplantation. Here, we report a case of human monocytic ehrlichiosis in a renal allograft recipient who presented with fever and clinical picture of TMA in the first month post-kidney transplant. Despite broad coverage with multiple antimicrobial agents, fever and hematological abnormalities persisted for several days. A history of contact exposure and living in an endemic area raised clinical suspicion for human monocytic ehrlichiosis (HME), and empiric treatment with doxycycline was initiated. Definitive diagnosis of HME was confirmed by polymerase chain reaction (PCR) for Ehrlichia chaffeensis. Human ehrlichiosis should be considered within the differential diagnosis in kidney transplant recipients with the clinical picture of TMA and fever of unknown origin. Furthermore, early treatment with doxycycline enhances rapid resolution of clinical and laboratory recovery.
Keyphrases
  • healthcare
  • staphylococcus aureus
  • squamous cell carcinoma
  • radiation therapy
  • rectal cancer
  • quantum dots
  • smoking cessation
  • replacement therapy
  • urinary tract infection